AR116493A1 - COMPOSITIONS AND METHODS TO TREAT PIGMENTARY RETINOSIS - Google Patents

COMPOSITIONS AND METHODS TO TREAT PIGMENTARY RETINOSIS

Info

Publication number
AR116493A1
AR116493A1 ARP190102707A ARP190102707A AR116493A1 AR 116493 A1 AR116493 A1 AR 116493A1 AR P190102707 A ARP190102707 A AR P190102707A AR P190102707 A ARP190102707 A AR P190102707A AR 116493 A1 AR116493 A1 AR 116493A1
Authority
AR
Argentina
Prior art keywords
compositions
methods
treat
retinosis
pigmentary retinosis
Prior art date
Application number
ARP190102707A
Other languages
Spanish (es)
Original Assignee
Nightstarx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nightstarx Ltd filed Critical Nightstarx Ltd
Publication of AR116493A1 publication Critical patent/AR116493A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La descripción se relaciona con composiciones y métodos para el tratamiento de la retinosis pigmentaria mediante la administración de un vector de rAAV, que comprende una secuencia de RPGRORF¹⁵.The description relates to compositions and methods for the treatment of retinitis pigmentosa by administering an rAAV vector, comprising a RPGRORF¹⁵ sequence.

ARP190102707A 2018-09-21 2019-09-23 COMPOSITIONS AND METHODS TO TREAT PIGMENTARY RETINOSIS AR116493A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862734746P 2018-09-21 2018-09-21

Publications (1)

Publication Number Publication Date
AR116493A1 true AR116493A1 (en) 2021-05-12

Family

ID=76217976

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190102707A AR116493A1 (en) 2018-09-21 2019-09-23 COMPOSITIONS AND METHODS TO TREAT PIGMENTARY RETINOSIS

Country Status (1)

Country Link
AR (1) AR116493A1 (en)

Similar Documents

Publication Publication Date Title
CL2018001152A1 (en) Compositions and methods for cancer treatment
CO2020009861A2 (en) PD-1 / PD-L1 inhibitors
MX2020012797A (en) Anti-pvrig/anti-tigit bispecific antibodies and methods of use.
CL2020000299A1 (en) Compounds, compositions and methods.
DOP2019000201A (en) HIV INHIBITING COMPOUNDS
CL2017000317A1 (en) Adjunctive therapy with 25-hydroxy vitamin d
CL2020000886A1 (en) 1-Benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as hiv protease inhibitors.
DOP2016000233A (en) HEPATITIS B CORE PROTEIN ANOSTERIC MODULATORS
JOP20200152A1 (en) Macrocyclic compounds for treating disease
CL2019002368A1 (en) Compositions and methods for the treatment of cancer.
MX2017001656A (en) Bruton's tyrosine kinase inhibitor combinations and uses thereof.
CO2021004934A2 (en) Compositions and methods for treating retinitis pigmentosa
MX2018009325A (en) Compounds and methods of treating rna-mediated diseases.
EA201890861A1 (en) COMPOSITIONS, CONTAINING LENTIVIRUS VECTORS, EXPRESSING IL-12, AND METHODS OF THEIR APPLICATION
ECSP21053104A (en) HSD17B13 EXPRESSION MODULATORS
MX2022006817A (en) Formulations/compositions comprising a btk inhibitor.
MX2018008903A (en) COMPOSITIONS AND METHODS OF USE OF ß-HYDROXY-ß-METHYLBUTYRATE (HMB) FOR MODULATING AUTOPHAGY AND LIPOPHAGY.
TN2017000047A1 (en) Azetidinyloxyphenylpyrrolidine compounds
PH12018501943A1 (en) Pharmaceutical compositions for the treatment of cancer
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
WO2018211324A8 (en) Prodrugs for the treatment of disease
AR116493A1 (en) COMPOSITIONS AND METHODS TO TREAT PIGMENTARY RETINOSIS
CO2021014747A2 (en) Methods for the treatment of beta-thalassemia
MX2021001018A (en) Compositions and methods of treating acne and photoaging.
MX2021002444A (en) Compounds and methods for treating fungal infections.

Legal Events

Date Code Title Description
FB Suspension of granting procedure